Notably, METTL1-mediated m7G modification drives leukemogenesis in acute myeloid leukemia (AML) by reprogramming tRNA-dependent translational control, illustrating how epitranscriptomic dysregulation interfaces with oncogenic pathways [105]. The gene discussed is METTL1; the disease is acute myeloid leukemia.